Active Pregnancy. Mental and Emotional Health Care to Pregnant Woman During and After Coronavirus (COVID-19)
Launched by UNIVERSIDAD POLITECNICA DE MADRID · Mar 24, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Active Pregnancy," is focused on understanding how mental and emotional health care can support pregnant women during and after the COVID-19 pandemic. Pregnancy can be a challenging time for many women, especially concerning their mental health. Common feelings like stress, anxiety, and depression can arise during this period, which may not only affect the mother but also have implications for the baby's health and development. The study aims to explore ways to help pregnant women manage these feelings to promote better outcomes for both mothers and their babies.
To participate in this trial, women need to be over 18 years old, pregnant with a single baby, and planning to deliver at one of the research hospitals. They should not be involved in any other exercise programs. However, certain health conditions like high blood pressure or complications with the pregnancy may prevent some women from participating. Those who join can expect to receive support and care specifically designed for their mental and emotional well-being throughout their pregnancy journey. It's important to note that this study is currently recruiting participants, allowing for better understanding and improvement of mental health care for pregnant women during these unique times.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Pregnant women fulfilling the following criteria: \>18 years old, singleton pregnancies and planning management and delivery at the research hospitals, and also do not participate in any other program of supervised physical exercise.
- Exclusion Criteria:
- Women with absolute contraindications. Women with relative contraindications need permission from obstetric care providers prior to participation:
- Absolute contraindications to exercise:
- • Ruptured membranes.
- • Premature labor.
- • Unexplained persistent vaginal bleeding.
- • Placenta praevia after 28 weeks gestation.
- • Pre-eclampsia.
- • Incompetent cervix.
- • Intrauterine growth restriction.
- • High-order multiple pregnancies (eg, triplets).
- • Uncontrolled type I diabetes.
- • Uncontrolled hypertension.
- • Uncontrolled thyroid disease.
- • Other serious cardiovascular, respiratory, or systemic disorders.
- Relative contraindications to exercise:
- • Recurrent pregnancy loss.
- • Gestational hypertension.
- • A history of spontaneous preterm birth.
- • Mild/moderate cardiovascular or respiratory disease.
- • Symptomatic anemia.
- • Malnutrition.
- • Eating disorder.
- • Twin pregnancy after the 28th week.
- • Other significant medical conditions.
- • Women in the CG were asked about their exercise once each trimester using a "Decision Algorithm" and those who are excessively actives were excluded.
About Universidad Politecnica De Madrid
The Universidad Politécnica de Madrid (UPM) is a leading institution in engineering and technology education, renowned for its commitment to innovation and research excellence. As a clinical trial sponsor, UPM leverages its interdisciplinary expertise to advance medical research and develop novel therapeutic solutions. The university fosters collaborations with healthcare professionals, industry partners, and research organizations to conduct rigorous clinical studies that aim to improve patient outcomes and contribute to the scientific community. With a strong emphasis on ethical practices and regulatory compliance, UPM is dedicated to enhancing the landscape of clinical research through its robust academic framework and cutting-edge facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Rubén Barakat, PhD
Study Director
Universidad Politécnica de Madrid (UPM)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials